Thus, the EDR peptide is capable of exerting neuroprotective and antiapoptotic effects through the MAPK/ERK signaling pathway, thus preventing the AD development under oxidative stress conditions (Figure 2). The gene discussed is PEG10; the disease is Alzheimer disease.